e-learning
resources
European Respiratory Review
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
What have we learned from basic science studies on idiopathic pulmonary fibrosis?
Toyoshi Yanagihara, Seidai Sato, Chandak Upagupta, Martin Kolb
Source:
Eur Respir Rev, 28 (153) 190029; 10.1183/16000617.0029-2019
Journal Issue:
September
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Toyoshi Yanagihara, Seidai Sato, Chandak Upagupta, Martin Kolb. What have we learned from basic science studies on idiopathic pulmonary fibrosis?. Eur Respir Rev, 28 (153) 190029; 10.1183/16000617.0029-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Asbestosis
Whole genome sequencing of the highly virulent subtype B0/W148 of the Beijing genotype M.tuberculosis in Kharkiv, East Ukraine
Related content which might interest you:
Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance?
Source: Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020
Year: 2020
Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science
Source: Eur Respir J 2016; 47:1615-1617
Year: 2016
Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 26 (145) 170050; 10.1183/16000617.0050-2017
Year: 2017
Idiopathic pulmonary fibrosis: current challenges and future perspectives
Source: Eur Respir Rev 2013; 22: 103-105
Year: 2013
Idiopathic pulmonary fibrosis: present understanding and future options
Source: Eur Respir Rev 2011; 20: 132-133
Year: 2011
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials
Source: Eur Respir J 2015; 46: 243-249
Year: 2015
Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models
Source: Eur Respir Rev 2014; 23:231-238
Year: 2014
Generalisability of recent clinical trials in idiopathic pulmonary fibrosis to everyday clinical practice
Source: International Congress 2015 – Treatment of IPF
Year: 2015
Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis
Source: Eur Respir Rev 2012; 21: 48-56
Year: 2012
Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences
Source: Eur Respir Rev 2015; 24: 420-427
Year: 2015
Insights into idiopathic pulmonary fibrosis in the real world
Source: Eur Respir J 2015; 46: 16-18
Year: 2015
Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?
Source: ERJ Open Res, 8 (1) 00422-2021; 10.1183/23120541.00422-2021
Year: 2022
A recurring theme in pulmonary fibrosis genetics
Source: Eur Respir J, 49 (5) 1700545; 10.1183/13993003.00545-2017
Year: 2017
Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential
Source: Eur Respir Rev, 26 (145) 170071; 10.1183/16000617.0071-2017
Year: 2017
Idiopathic pulmonary fibrosis: recent milestones in disease management
Source: Eur Respir Rev 2012; 21: 140
Year: 2012
Does adventitious sound reflect the physiology of idiopathic pulmonary fibrosis (IPF)?
Source: Eur Respir J 2007; 30: Suppl. 51, 578s
Year: 2007
Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice
Source: Eur Respir Rev, 26 (146) 170094; 10.1183/16000617.0094-2017
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept